What's breaking now, across thousands of outlets.
(MedPage Today) -- Growing evidence linked GLP-1 drugs to a reduced risk of exacerbations of two types of chronic airways disease: asthma and chronic obstructive pulmonary disease (COPD). Based on real-world records from the U.K., affected patients...
We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.
The strain of mpox behind the 2022 outbreak was a weakened form of the virus, which may have helped it spread faster, a new study from the University of Surrey reports.
Washington is phasing out direct HIV financing for Namibia after the country met UNAIDS targets, leaving over 29,000 people facing the loss of support services.
The moves bring stability to an agency that's been rocked by the exits of top leadership.
Severe eosinophilic asthma can now be treated with biologic therapies that reduce attacks and, in some cases, allow corticosteroid dose reductions.
Mutant NRAS has remained difficult to target in cancer. New findings suggest that its signaling partnership with wild-type HRAS may offer a targetable vulnerability, but effective strategies may need…
For Samantha Banton, accessing an endometriosis diagnosis in WA's Pilbara took a significant toll on her mental health, and new research indicates she is not alone.
